Investors
Christoph Prußeit
Chief Innovation Officer, CINO
Born: 1988
Nationality: German
First appointed: January 1, 2019
Appointed until: July 31, 2027
Christoph Prußeit studied Pharmacy at the Eberhard Karls University of Tübingen. He began his career in 2014 at BerlinApotheke Schneider & Oleski OHG where, as a specialist pharmacist, he became manager of the Sterile Laboratory business area.
Christoph Prußeit has extensive practical experience in preparing patient-specific therapies in strict compliance with the highest quality standards. This makes him a recognized expert in pharmaceutical manufacturing and drug safety.
He is responsible for the departments IT, IT Security and Project Management as well as Digital Innovation and Public Affairs and Privacy. Furthermore, he is responsible for the business segment Patient-Specific Therapies.
External positions:
Christoph Prußeit is currently not a member of any supervisory board or controlling body.
Receive e-mail updates on the latest news and the publication of financial reports. This will automatically keep you up to date.
Registration is free of charge and can be revoked at any time.
Claudia Nickolaus
Head of Investor & Public Relations ESG Communications
+49 30 232 566 800
ir@medios.group
